PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Ascentage Pharma Grp International (6855.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG0519B1023
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$5.83B
Revenue (TTM)HK$221.98M
Gross Profit (TTM)HK$24.58M
EBITDA (TTM)-HK$812.82M
Year RangeHK$15.42 - HK$28.15
Target PriceHK$30.39

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Ascentage Pharma Grp International

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in Ascentage Pharma Grp International, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%80.00%December2024FebruaryMarchAprilMay
-44.68%
73.43%
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

S&P 500

Returns By Period

Ascentage Pharma Grp International had a return of -23.81% year-to-date (YTD) and 4.84% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-23.81%11.05%
1 month23.66%4.86%
6 months-19.22%17.50%
1 year4.84%27.37%
5 years (annualized)N/A13.14%
10 years (annualized)N/A10.90%

Monthly Returns

The table below presents the monthly returns of 6855.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-15.75%12.61%-31.43%0.68%-23.81%
202316.54%-16.69%-10.42%2.46%-10.92%3.43%13.03%1.26%-13.46%21.53%0.59%6.85%6.23%
2022-28.72%-9.05%-7.66%-19.91%28.85%22.27%-24.79%2.62%-27.98%31.93%40.52%17.08%-8.87%
20217.92%-17.81%-11.13%25.21%25.53%-1.47%-3.09%-15.26%-10.49%-16.21%12.26%-13.23%-26.75%
2020-10.83%-0.93%-15.47%47.32%-12.42%63.32%-32.73%5.51%-15.07%-4.39%-2.21%44.74%28.33%
2019-7.58%-4.32%-9.77%-20.21%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 6855.HK is 39, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of 6855.HK is 3939
6855.HK (Ascentage Pharma Grp International)
The Sharpe Ratio Rank of 6855.HK is 4040Sharpe Ratio Rank
The Sortino Ratio Rank of 6855.HK is 3939Sortino Ratio Rank
The Omega Ratio Rank of 6855.HK is 3939Omega Ratio Rank
The Calmar Ratio Rank of 6855.HK is 4141Calmar Ratio Rank
The Martin Ratio Rank of 6855.HK is 3939Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Ascentage Pharma Grp International (6855.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


6855.HK
Sharpe ratio
The chart of Sharpe ratio for 6855.HK, currently valued at -0.07, compared to the broader market-2.00-1.000.001.002.003.004.00-0.07
Sortino ratio
The chart of Sortino ratio for 6855.HK, currently valued at 0.29, compared to the broader market-4.00-2.000.002.004.006.000.29
Omega ratio
The chart of Omega ratio for 6855.HK, currently valued at 1.04, compared to the broader market0.501.001.502.001.04
Calmar ratio
The chart of Calmar ratio for 6855.HK, currently valued at -0.05, compared to the broader market0.002.004.006.00-0.05
Martin ratio
The chart of Martin ratio for 6855.HK, currently valued at -0.23, compared to the broader market-10.000.0010.0020.0030.00-0.23
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.49, compared to the broader market-2.00-1.000.001.002.003.004.002.49
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.006.003.52
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.43, compared to the broader market0.501.001.502.001.43
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.03, compared to the broader market0.002.004.006.002.03
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.57, compared to the broader market-10.000.0010.0020.0030.009.57

Sharpe Ratio

The current Ascentage Pharma Grp International Sharpe ratio is -0.07. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Ascentage Pharma Grp International with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.07
2.45
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

Dividends

Dividend History


Ascentage Pharma Grp International doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-62.39%
-0.32%
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Ascentage Pharma Grp International. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ascentage Pharma Grp International was 79.31%, occurring on Oct 7, 2022. The portfolio has not yet recovered.

The current Ascentage Pharma Grp International drawdown is 62.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-79.31%Jul 23, 2021299Oct 7, 2022
-50.8%Jul 8, 202098Nov 26, 202040Jan 25, 2021138
-48.25%Nov 7, 201993Mar 23, 202057Jun 16, 2020150
-43.18%Jan 26, 202143Mar 29, 202171Jul 14, 2021114
-10.29%Jul 15, 20213Jul 19, 20212Jul 21, 20215

Volatility

Volatility Chart

The current Ascentage Pharma Grp International volatility is 11.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%December2024FebruaryMarchAprilMay
11.72%
3.42%
6855.HK (Ascentage Pharma Grp International)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ascentage Pharma Grp International over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items